OMIM 601728; Eng 2003).0 / 1.18M alleles).0.72 (top 3 of deck) → auto-flagged for ABOPM faculty re-review.cards.search + variant.pull_anchors… Card #17 · PTEN c.388C>T. Cohort difficulty 0.72. Pulling anchors: ClinVar/VCV000128037 · ClinGen/PTEN-VCEP · COSMIC/PTEN · OMIM/158350.cohort.difficulty_signal… 62% first-pass pick mismatch repair. Correct path: PTEN → PI3K/AKT/mTOR → epithelial proliferation in AYA gastric. ACMG verdict PVS1 + PM2_S + PP4_S → Pathogenic per Richards 2015 + ClinGen PTEN VCEP.Foundation One F1CDx tumor profile for case-001 · PTEN c.388C>T at 48% VAF · TMB-low · MSS · HRD-positive signature. gnomAD v4.1 non-cancer: 0/1.18M alleles (absent across 7 ethnicities). Foundation report tacks to case-001 on merge.ANKI_CARD_REVIEW. Your read tacks onto case-001's hash chain as new evidence. ABOPM faculty re-sign on cohort threshold. To generate NEW peer-signed evidence, open CaseChat and draft from a clinical narrative; I'll walk the ACMG/AMP criteria.PTEN c.388C>T) with full ACMG/AMP detail. The details are the evidence.PVS1 + PM2_Supporting + PP4_Strong → Pathogenic. Every criterion cites Richards 2015 + the ClinGen PTEN VCEP rules spec.ANKI_CARD_REVIEW and hash-chains to case-001.